The hot weight-loss drug Wegovy is in short supply and high demand.  The drug has proven to help people lose as much as 15% of their weight by suppressing appetite, but the company expected a more gradual adoption of the drug and has lost out on a ton of potential cash.  Selling only $700 million to date, analysts had projected $2 billion in sales for 2021 and 2022.  Peter Loftus, pharma reporter at the WSJ, joins us for why you can’t find Wegovy.   Next, the Real ID requirement for air travel has been delayed once again.  Americans will have two more years, until May 2025 to go to the DMV and provide the proper paperwork.  The deadline was extended to help DMVs with pandemic related setbacks.  To date, only about 49% of people have gotten their updated IDs.  Luz Lazo, transportation reporter at The Washington Post, joins us for what to know.   Finally, a pair of marijuana bills may be attached to “must-pass” year-end bills in Congress.  A bipartisan group of senators will be trying to add the SAFE Banking Act to allow cannabis businesses to access loans and open bank accounts and the HOPE Act, which would provide grants to states that expunge former convictions.  Sophia Cai, congressional reporter at Axios, joins us for the plan to pass pot legislation. See omnystudio.com/listener for privacy information.